1. Home
  2. Bills
  3. S. 3751

S. 3751 · 111th Congress · 2009–2010

Stem Cell Therapeutic and Research Reauthorization Act of 2010

S. 3751 in the 111th Congress (2009–2010) became law — introduced on Aug 5, 2010, sponsored by Orrin G. Hatch with 12 co-sponsors.

During the 111th Congress (2009–2010), Barack Obama was president, and Democrats held majorities in both the House and Senate.

Status
Became law
Introduced
Aug 5, 2010
Co-sponsors
12
Policy area
Health
Public law
Public Law 111-264

What it does

Stem Cell Therapeutic and Research Reauthorization Act of 2010 - (Sec. 2) Amends the Stem Cell Therapeutic and Research Act of 2005 to revise provisions related to the National Cord Blood Inventory (the Inventory), including to establish an inventory goal of at least 150,000 new units of cord blood to be made available under the C.W. Bill Young Cell Transplantation Program (the Program).

Summary by the nonpartisan Congressional Research Service.

Sponsor

Orrin G. Hatch (R-UT). Co-sponsors: 8 Democrats, 4 Republicans.

Where it stands

  • IntroducedAug 5, 2010
  • Passed the SenateSep 28, 2010
  • Passed the HouseSep 30, 2010
  • Sent to the PresidentOct 4, 2010
  • Became lawOct 8, 2010

Latest action: Became Public Law No: 111-264. (Oct 8, 2010)

Other Health bills in the 111th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “S. 3751 (111th Congress): Stem Cell Therapeutic and Research…,” https://www.capitolreceipts.com/bill/111-s-3751/stem-cell-therapeutic-and-research-reauthorization-act-of-2010 (accessed 2026-10-17).